ascopubs.org

A blind validation of a deep-learning solution providing HER2, ER, and PR results from H&E-stained breast cancer specimens.

Evaluating the association between radiomic features on breast MRI and dormant tumor cell presence in the SURMOUNT trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
ascopubs.org

Real-world and clinical trial validation of a deep learning radiomic biomarker for PD-(L)1 immune checkpoint inhibitor response in stage IV NSCLC.

Multimodal artificial intelligence models from baseline histopathology to predict prognosis in HR+ HER2- early breast cancer: Subgroup analysis. This is an ASCO Meeting Abstract from the 2024 ASCO ...